• Home
  •  / Emisphere Technologies

Emisphere Technologies

OverviewSuggest Edit

Emisphere Technologies is a commercial-stage pharmaceutical and drug delivery company. It develops the Eligen drug delivery technology that facilitates oral absorption of biologics products. The Company also provides Eligen B12, an oral medical food that normalizes B12 level.
TypePublic
Founded1986
HQRoseland, USMap
Websiteemisphere.com

Recent NewsAll News

Latest Updates

Employees (est.) (Feb 2019)6(-50%)
Revenue (FY, 2016)$1.2 M(+191%)
Share Price (Sept 2020)$8.2 (+2%)
Cybersecurity ratingAMore

Key People/Management at Emisphere Technologies

M. Gary I. Riley

M. Gary I. Riley

Chief Scientific Officer
Phil Nikolayuk

Phil Nikolayuk

Director of Finance
David Gschneidner Ph

David Gschneidner Ph

Vice President, Carrier R&D
John D. Harkey

John D. Harkey

Director
Louis Stamatellos

Louis Stamatellos

Director, Global Supply
Tim McInerney

Tim McInerney

Director
Show more

Emisphere Technologies Office Locations

Emisphere Technologies has an office in Roseland
Roseland, US (HQ)
4 Becker Farm Rd
Show all (1)

Emisphere Technologies Financials and Metrics

Emisphere Technologies Revenue

Emisphere Technologies's revenue was reported to be $1.20 m in FY, 2016 which is a 190.8% increase from the previous period.
USD

Revenue (Q1, 2017)

222.0k

Gross profit (Q1, 2017)

175.0k

Gross profit margin (Q1, 2017), %

78.8%

Net income (Q1, 2017)

6.1m

EBIT (Q1, 2017)

(1.1m)

Market capitalization (16-Sept-2020)

689.7m

Closing stock price (16-Sept-2020)

8.2

Cash (31-Mar-2017)

4.6m
Emisphere Technologies's current market capitalization is $689.7 m.
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Revenue

411.0k1.2m

Revenue growth, %

191%

Cost of goods sold

892.0k286.0k

Gross profit

(481.0k)909.0k
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Revenue

6.0k88.0k130.0k373.0k286.0k204.0k222.0k

Cost of goods sold

25.0k55.0k58.0k52.0k46.0k41.0k47.0k

Gross profit

(19.0k)33.0k72.0k321.0k240.0k163.0k175.0k

Gross profit Margin, %

(317%)38%55%86%84%80%79%
show all
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Cash

3.1m1.5m4.1m3.7m12.9m6.1m

Accounts Receivable

22.0k1.0k455.0k301.0k

Prepaid Expenses

581.0k149.0k622.0k188.0k1.1m

Inventories

258.0k249.0k230.0k2.1m1.3m67.0k
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Cash

1.3m4.7m3.2m1.4m229.0k63.0k7.7m6.1m2.9m1.0m4.0m4.8m3.2m1.4m10.4m8.7m7.5m4.6m

Accounts Receivable

60.0k35.0k4.0k4.0k3.0k2.0k248.0k130.0k305.0k297.0k246.0k232.0k239.0k

Prepaid Expenses

535.0k483.0k510.0k577.0k535.0k160.0k147.0k80.0k615.0k615.0k354.0k418.0k1.1m722.0k769.0k448.0k194.0k230.0k

Inventories

260.0k258.0k258.0k258.0k258.0k249.0k249.0k249.0k230.0k231.0k694.0k2.1m2.8m2.1m1.3m656.0k85.0k50.0k
show all
Annual
USDFY, 2011FY, 2012FY, 2013FY, 2014FY, 2015FY, 2016

Net Income

15.1m(1.9m)(20.9m)(25.4m)(40.4m)(10.0m)

Depreciation and Amortization

277.0k29.0k9.0k15.0k14.0k12.0k

Inventories

2.0k9.0k19.0k(1.4m)728.0k59.0k

Accounts Payable

(2.5m)29.0k615.0k306.0k274.0k(1.3m)
Quarterly
USDQ2, 2011Q3, 2011Q1, 2012Q2, 2012Q3, 2012Q1, 2013Q2, 2013Q3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2017

Net Income

12.8m(4.8m)(736.0k)2.0m(2.6m)(2.4m)(16.4m)(18.1m)(3.4m)(11.4m)(25.8m)(33.0m)(25.8m)(30.3m)(1.8m)(9.3m)(14.5m)6.1m

Depreciation and Amortization

140.0k210.0k7.0k15.0k23.0k2.0k4.0k6.0k4.0k7.0k11.0k3.0k7.0k10.0k4.0k8.0k11.0k

Inventories

2.0k(1.0k)(154.0k)(46.0k)(734.0k)14.0k17.0k30.0k41.0k17.0k

Accounts Payable

(1.1m)(2.4m)167.0k(239.0k)(55.0k)211.0k(188.0k)(102.0k)(507.0k)(936.0k)(528.0k)1.1m278.0k(174.0k)(472.0k)(1.2m)(1.3m)(80.0k)
show all
Show all financial metrics

Emisphere Technologies Cybersecurity Score

Cybersecurity ratingPremium dataset

A

96/100

Learn more about about our premium products
SecurityScorecard logo

Emisphere Technologies Online and Social Media Presence

Emisphere Technologies's Trends

Embed Graph

Emisphere Technologies News and Updates

January 04, 2019

Oral Drug Delivery 2018 Global Market Key Players - Encap, Skyepharma, Aegis Therapeutics, Aptalis, Flamel Technologies, Alkermes, Ethypharm, Emisphere Technologies......

Oral Drug Delivery – Global Market Growth, Opportunities, Analysis Of Top Key Players And Forecast To 2023 Posted via Industry Today. Follow us on Twitter @IndustryToday

 Emisphere Technologies Frequently Asked Questions

  • When was Emisphere Technologies founded?

    Emisphere Technologies was founded in 1986.

  • Who are Emisphere Technologies key executives?

    Emisphere Technologies's key executives are M. Gary I. Riley, Phil Nikolayuk and David Gschneidner Ph.

  • How many employees does Emisphere Technologies have?

    Emisphere Technologies has 6 employees.

  • What is Emisphere Technologies revenue?

    Latest Emisphere Technologies annual revenue is $1.2 m.

  • What is Emisphere Technologies revenue per employee?

    Latest Emisphere Technologies revenue per employee is $199.2 k.

  • Who are Emisphere Technologies competitors?

    Competitors of Emisphere Technologies include Reata Pharmaceuticals, Otonomy and MyoKardia.

  • Where is Emisphere Technologies headquarters?

    Emisphere Technologies headquarters is located at 4 Becker Farm Rd, Roseland.

  • Where are Emisphere Technologies offices?

    Emisphere Technologies has an office in Roseland.

  • How many offices does Emisphere Technologies have?

    Emisphere Technologies has 1 office.